Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Methyl-1H-indole-4-carboxylic acid (2MICA) is a cyclic compound that is used in the synthesis of other compounds. It is obtained by reacting 2,3-dibromo-nitrobenzoic acid with sodium ethoxide in an alkaline solution. The yield of 2MICA can be increased by using catalytic acid anhydrides such as dimethyl sulphoxide or lactam. In the presence of reductive agents, 2MICA can be synthesized from the corresponding lactam or cyclised carboxylic acid.<br>2MICA reacts with sodium ethoxide to form a lactam and reduces 2-bromo-3-nitrobenzoic acid to yield 2MICA.</p>

<p>5-Phenylpyrazolidin-3-one is a pyrazole compound that has a tautomeric form. It has been shown to selectively interact with anions, such as chloride anion, in the presence of hydrogen bonds. This leads to the production of a hydrogen cation and an electrophilic imine. 5-Phenylpyrazolidin-3-one is used in chemosensors for the detection of various chemicals, including formaldehyde and acetaldehyde. 5-Phenylpyrazolidin-3-one also has antitumor activity due to its ability to inhibit DNA synthesis and induce apoptosis in cancer cells.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Oxononanoic acid is a fatty acid that inhibits the binding of diagnostic agents to interleukin receptors. 2-Oxononanoic acid has been shown to inhibit the production of reactive oxygen species, which may be due to its acidic pH. This compound also inhibits the release of inflammatory mediators, such as cytokines and arachidonic acid metabolites. 2-Oxononanoic acid has been shown to have therapeutic potential in autoimmune diseases and infectious diseases, such as HIV/AIDS. 2-Oxononanoic acid is an affinity ligand for fatty acids and can be used in conjugates with antibodies or antigens for diagnostic purposes or therapy.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-(1-Chloroethyl)-5-(thiophen-2-yl)-3H,4H-thieno[2,3-d]pyrimidin-4-one is a small molecule that has been shown to inhibit the activity of calcium channels. It is also known as an inhibitor for research and antibody production. 2-(1-Chloroethyl)-5-(thiophen-2-yl)-3H,4H-thieno[2,3-d]pyrimidin-4-one is a ligand that binds to ion channels and activates them by binding to the receptor on the cell surface. This compound can be used in pharmacology and protein interactions.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Tert-butyl (2S)-2-aminohexanoate is an intermediate that is used in the synthesis of glycine by the reaction of benzyl bromide and tert-butyl amine. The stereospecifically incorporated tert-butyl group has a high degree of enantioselectivity, which makes this intermediate useful in the synthesis of glycine. Tert-butyl (2S)-2-aminohexanoate can be synthesized using lithium diisopropylamide and a tertiary amine as an alkylating agent.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3,8-Diethyl 4-aminopyrazolo[3,2-c][1,2,4]triazine-3,8-dicarboxylate is a structural formula that contains nitrogen atoms and a hydroxyl group. The alkylthio group and alkynyl groups are attached to the nitrogens on the 3 and 8 positions. This drug has been shown to be effective in treating chronic bronchitis, depression, and inflammatory diseases such as ischemia reperfusion injury. It also has a solid catalyst property which may be due to its ability to form complexes with dodecanedioic acid.</p>

<p>Versatile small molecule scaffold</p>

<p>1-Benzothiophene-6-carboxaldehyde (BTA) is a heterocyclic compound that contains sulfur. It is a colorless liquid with a sweet odor. BTA is used in the manufacture of pesticides, pharmaceuticals, and other organic chemicals. It is also used as a building block in the synthesis of other compounds and has been shown to have anti-inflammatory properties.</p>

<p>2-Hydroxy-4,6-dimethylbenzoic acid (HMBA) is a tumor treatment drug that can be used in combination with other drugs. HMBA inhibits proton pumps and the synthesis of DNA, RNA, and protein. The proton pump inhibitors are used to treat acid reflux disease, ulcers, and gastroesophageal reflux disease. HMBA has been shown to significantly inhibit tumor growth in animal studies. This drug also has anti-inflammatory effects and may be useful for treating arthritis.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Pyrazolo[1,5-a]pyridin-4-ol is a heteroaromatic compound that acts as an inhibitor of phosphodiesterase (PDE). It prevents the breakdown of cyclic nucleotides and thus leads to increased levels of cAMP and cGMP. Pyrazolo[1,5-a]pyridin-4-ol has been shown to have bronchodilatory activity in animal models. The drug also inhibits the production of inflammatory mediators such as prostaglandins by inhibiting cyclooxygenases. In addition, pyrazolo[1,5-a]pyridin-4-ol has been shown to be a potential PDE inhibitor replacement for the more commonly used PDE inhibitors such as sildenafil and tadalafil. However, due to its lack of stereochemistry and its bicyclic chemical structure, pyrazolo[1,5-a]</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>